• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Two COVID-19 papers published in PLOS ONE

Bioengineer by Bioengineer
March 31, 2020
in Health
Reading Time: 4 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Studies use SIRD model to forecast COVID-19 spread; examine patient CT scans to correlate clinical features with mortality

IMAGE

Credit: Yuan et al, 2020 (CC BY 4.0)

Two studies of the coronavirus COVID-19 outbreak recently published in the open-access journal PLOS ONE.

The first study, published March 31, 2020, was conducted by Constantinos Siettos from the Universita degli Studi di Napoli Federico II, Italy and colleagues. The authors used a Susceptible-Infected-Recovered-Dead (SIRD) model calibrated with the reported data between January 11 and February 10, 2020 and forecasted the evolution of the outbreak in the epicenter of the outbreak, Hubei, China up until February 29. With these parameters, they forecasted that at least 45,000 would be infected and 2,700 would die by February 29 – in fact, in Hubei, around 67,000 are known to have become infected, while the death toll was around 2800 in this time period.

The authors also used the SIRD model to estimate COVID-19’s R0 value, an estimate of contagiousness which reflects the average number of people who may catch an infection from one contagious person. Across various scenarios, their estimate of R0 based on the available data was around 2.5. Assuming a high degree of underreporting of mild cases of COVID-19 in their data, they estimated a mortality rate in the total population of around 0.15% for the virus. Furthermore, based on a scenario assuming an order of 20-fold scaling of the number of infected in the total population, their study predicted a decline of the outbreak at the end of February in Hubei. Indeed, during the last days the number of new infected cases has dropped significantly.

Dr Siettos notes: “This is the first study based on a mathematical modelling approach that has provided relatively accurate three- week-ahead forecasts. Importantly, to the best of our knowledge this is the first study based on a mathematical modelling approach suggesting that the actual number of the infections in the total population is of the order of twenty times more than those reported, and that the mortality rate in the total population is about ~0.15% i.e. significantly less than reported 2-3%.Our findings imply that for the case of Hubei (with a 60m population), around 2%-3% of the total population in Hubei has been actually infected by coronavirus.”

The second study, published March 19, 2020, was conducted by Mingli Yuan and colleagues from the Central Hospital of Wuhan, Hubei province, China. The researchers studied 27 patients infected with COVID-19 and admitted to the Central Hospital of Wuhan.

In this patient group, the authors associated clinical features identified from computed tomography (CT) scans of patients’ lungs with eventual outcomes. They scored patients based on features they observed such as ground glass opacity, abnormality on both sides, and widespread distribution of pathology in the lungs, to produce an overall severity score for each patient.

Of the 27 patients, who were mostly older adults (median age 60), 17 (63 percent) recovered and were discharged from hospital, while 10 (37 percent) died of the virus. Patients with underlying health conditions including hypertension, diabetes and cardiac disease were more likely to die of the virus than patients without such comorbidities, and older patients were also more likely to die, though there was no difference between genders. Patients with a higher (more severe) score at CT scan were much more likely to die of COVID-19 – the average score of patients who died was 30, compared to 12 in patients who recovered.

Dr Yuan adds: “This study allows us to compare radiologic findings with the mortality of patients infected with COVID-19.”

###

Information for Siettos/Anastassopoulou et al paper:

Citation: Anastassopoulou C, Russo L, Tsakris A, Siettos C (2020) Data-based analysis, modelling and forecasting of the COVID-19 outbreak. PLoS ONE 15(4): e0230405. https://doi.org/10.1371/journal.pone.0230405

Funding: The authors received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

In your coverage please use this URL to provide access to the freely available article in PLOS ONE: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0230405

Information for Yuan et al paper:

Citation: Yuan M, Yin W, Tao Z, Tan W, Hu Y (2020) Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS ONE 15(3): e0230548. https://doi.org/10.1371/journal.pone.0230548

Funding: The authors received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

In your coverage please use this URL to provide access to the freely available article in PLOS ONE: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0230548

Media Contact
Constantinos Siettos
[email protected]

Original Source

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0230405

Related Journal Article

http://dx.doi.org/10.1371/journal.pone.0230405

Tags: Medicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Revolutionizing Heart Health: Targeting Autonomic Nervous System

October 11, 2025

Unveiling Mental Health Challenges in Autistic Girls

October 11, 2025

Link Between Nurse Practices and CAUTI Rates

October 11, 2025

Plasma Exosome Proteomics in Metastatic Colorectal Cancer

October 11, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1214 shares
    Share 485 Tweet 303
  • New Study Reveals the Science Behind Exercise and Weight Loss

    102 shares
    Share 41 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    99 shares
    Share 40 Tweet 25
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    88 shares
    Share 35 Tweet 22

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionizing Heart Health: Targeting Autonomic Nervous System

Unveiling Mental Health Challenges in Autistic Girls

Soft Exosuit Enhances Shoulder and Elbow Function Post-Injury

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.